Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Risk Assessment generated by a regulatory process
(RA)
last updated: 13 Dec 2018
Biotechnology Consultation Memorandum of Video-Conference BNF No. 000025
EN
-
Competent National Authority:U.S. Food and Drug Administration ()DHHS/FDA/CFSAN 5100 Paint Branch ParkwayCollege Park, MD
20740, USAPhone:Fax:Email: biotechfood@fda.gov,Website:
-
CGN-89111-8 - High oleic acid canola| Monsanto (Calgene) | Production of medical or pharmaceutical compounds (human or animal) (Omega-3 fatty acids (e.g. DHA)), Resistance to antibiotics (Kanamycin)
- U.S. Food and Drug Administration [ English ]
EN
| Record type | Field | Record(s) | |
|---|---|---|---|
| Country's Decision or any other Communication | Risk assessment | 2 | |
